NCT01024413 2017-03-01Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 MutationsChinese Society of Lung CancerPhase 3 Completed256 enrolled
NCT01039948 2015-04-08A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerAVEO Pharmaceuticals, Inc.Phase 1/2 Completed203 enrolled